Arena Pharmaceuticals (FRA:RN3N) Effective Interest Rate on Debt % : 9.81% (As of Dec. 2021)

View and export this data going back to 2000. Start your Free Trial

What is Arena Pharmaceuticals Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Arena Pharmaceuticals's annualized positive value of Interest Expense for the quarter that ended in Dec. 2021 was €3.56 Mil. Arena Pharmaceuticals's average total debt for the quarter that ended in Dec. 2021 was €36.24 Mil. Therefore, Arena Pharmaceuticals's annualized Effective Interest Rate on Debt % for the quarter that ended in Dec. 2021 was 9.81%.

Arena Pharmaceuticals Effective Interest Rate on Debt % Historical Data

The historical data trend for Arena Pharmaceuticals's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arena Pharmaceuticals Effective Interest Rate on Debt % Chart

Arena Pharmaceuticals Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Effective Interest Rate on Debt %

Get a 7-Day Free Trial

8.34

10.16

9.50

9.07

9.95

Arena Pharmaceuticals Quarterly Data
	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21
Effective Interest Rate on Debt %	Get a 7-Day Free Trial															9.35	3.44	9.48	9.72	9.81

Competitive Comparison of Arena Pharmaceuticals's Effective Interest Rate on Debt %

For the Biotechnology subindustry, Arena Pharmaceuticals's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Arena Pharmaceuticals's Effective Interest Rate on Debt % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arena Pharmaceuticals's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Arena Pharmaceuticals's Effective Interest Rate on Debt % falls into.

Arena Pharmaceuticals Effective Interest Rate on Debt % Calculation

Arena Pharmaceuticals's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2021 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (A: Dec. 2020 )	+	Total Debt (A: Dec. 2021 ))	/ count )
=	-1 * -3.681	/	( (37.493	+	36.472)	/ 2 )
=	-1 * -3.681	/	36.9825
=	9.95 %

where

	Total Debt (A: Dec. 2020 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	33.875	+	3.618
=	37.493

	Total Debt (A: Dec. 2021 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	32.001	+	4.471
=	36.472

Arena Pharmaceuticals's annualized Effective Interest Rate on Debt % for the quarter that ended in Dec. 2021 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (Q: Sep. 2021 )	+	Total Debt (Q: Dec. 2021 ))	/ count )
=	-1 * -3.556	/	( (36.013	+	36.472)	/ 2 )
=	-1 * -3.556	/	36.2425
=	9.81 %

where

	Total Debt (Q: Sep. 2021 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	31.862	+	4.151
=	36.013

	Total Debt (Q: Dec. 2021 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	32.001	+	4.471
=	36.472

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Dec. 2021) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

Arena Pharmaceuticals (FRA:RN3N) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.

Arena Pharmaceuticals Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Arena Pharmaceuticals's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.

Arena Pharmaceuticals (FRA:RN3N) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arena Pharmaceuticals Inc (FRA:RN3N) » Definitions » Effective Interest Rate on Debt %

Comparable Companies

Traded in Other Exchanges

N/A

Address

136 Heber Avenue, Suite 204, Park City, UT, USA, 84060

Website

https://www.arenapharm.com

Arena Pharmaceuticals is a biotechnology company targeting G-protein-coupled receptors. The company has one internally discovered drug, lorcaserin, which has been approved and is marketed in the U.S. and South Korea to target weight management. It is commercialized under the brand name Belviq. The company is collaborating with Eisai to market Belviq in other countries. It has a presence in Europe through its Swiss subsidiary, Arena GmbH. The company's pipeline contains drugs targeting autoimmune diseases, vascular diseases, thrombotic diseases, dementia-associated psychosis, nervous system issues, and pain.

Arena Pharmaceuticals (FRA:RN3N) Headlines

No Headlines